761 related articles for article (PubMed ID: 22336846)
1. Short and long term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; D'Amico R; Bassi C; Basevi V; Marata AM; Magrini N; Maestri E
Cochrane Database Syst Rev; 2012 Feb; (2):CD008536. PubMed ID: 22336846
[TBL] [Abstract][Full Text] [Related]
2. Short-term and long-term effects of tibolone in postmenopausal women.
Formoso G; Perrone E; Maltoni S; Balduzzi S; Wilkinson J; Basevi V; Marata AM; Magrini N; D'Amico R; Bassi C; Maestri E
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD008536. PubMed ID: 27733017
[TBL] [Abstract][Full Text] [Related]
3. Add-back therapy with GnRH analogues for uterine fibroids.
Moroni RM; Martins WP; Ferriani RA; Vieira CS; Nastri CO; Candido Dos Reis FJ; Brito LG
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010854. PubMed ID: 25793972
[TBL] [Abstract][Full Text] [Related]
4. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy for sexual function in perimenopausal and postmenopausal women.
Nastri CO; Lara LA; Ferriani RA; Rosa-E-Silva AC; Figueiredo JB; Martins WP
Cochrane Database Syst Rev; 2013 Jun; (6):CD009672. PubMed ID: 23737033
[TBL] [Abstract][Full Text] [Related]
6. Long-term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
[TBL] [Abstract][Full Text] [Related]
7. Long term hormone therapy for perimenopausal and postmenopausal women.
Farquhar CM; Marjoribanks J; Lethaby A; Lamberts Q; Suckling JA;
Cochrane Database Syst Rev; 2005 Jul; (3):CD004143. PubMed ID: 16034922
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone for women in the peri- or postmenopausal phase.
Scheffers CS; Armstrong S; Cantineau AE; Farquhar C; Jordan V
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD011066. PubMed ID: 25879093
[TBL] [Abstract][Full Text] [Related]
10. Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
Sismondi P; Kimmig R; Kubista E; Biglia N; Egberts J; Mulder R; Planellas J; Moggio G; Mol-Arts M; Kenemans P
Maturitas; 2011 Dec; 70(4):365-72. PubMed ID: 22030384
[TBL] [Abstract][Full Text] [Related]
11. Bioidentical hormones for women with vasomotor symptoms.
Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
[TBL] [Abstract][Full Text] [Related]
12. Acupuncture for menopausal hot flushes.
Dodin S; Blanchet C; Marc I; Ernst E; Wu T; Vaillancourt C; Paquette J; Maunsell E
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007410. PubMed ID: 23897589
[TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine for menopausal symptoms.
Zhu X; Liew Y; Liu ZL
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009023. PubMed ID: 26976671
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
Lethaby A; Suckling J; Barlow D; Farquhar CM; Jepson RG; Roberts H
Cochrane Database Syst Rev; 2004; (3):CD000402. PubMed ID: 15266429
[TBL] [Abstract][Full Text] [Related]
15. Long term hormone therapy for perimenopausal and postmenopausal women.
Farquhar C; Marjoribanks J; Lethaby A; Suckling JA; Lamberts Q
Cochrane Database Syst Rev; 2009 Apr; (2):CD004143. PubMed ID: 19370593
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor modulators for endometriosis.
Fu J; Song H; Zhou M; Zhu H; Wang Y; Chen H; Huang W
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009881. PubMed ID: 28742263
[TBL] [Abstract][Full Text] [Related]
17. Local oestrogen for vaginal atrophy in postmenopausal women.
Lethaby A; Ayeleke RO; Roberts H
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD001500. PubMed ID: 27577677
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Kenemans P; Bundred NJ; Foidart JM; Kubista E; von Schoultz B; Sismondi P; Vassilopoulou-Sellin R; Yip CH; Egberts J; Mol-Arts M; Mulder R; van Os S; Beckmann MW;
Lancet Oncol; 2009 Feb; 10(2):135-46. PubMed ID: 19167925
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
20. Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer.
Nelson HD; Fu R; Griffin JC; Nygren P; Smith ME; Humphrey L
Ann Intern Med; 2009 Nov; 151(10):703-15, W-226-35. PubMed ID: 19920271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
